These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19440569)

  • 21. Clozapine-induced dysphagia with secondary substantial weight loss.
    Osman M; Devadas V
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27543610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine-associated pneumonia and respiratory arrest secondary to severe constipation.
    Galappathie N; Khan S
    Med Sci Law; 2014 Apr; 54(2):105-9. PubMed ID: 24052002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of rechallenge clozapine after agranulocytosis: A case report.
    Roméo B; Petillion A; Martelli C; Benyamina A
    Encephale; 2019 Nov; 45(5):449-450. PubMed ID: 30878138
    [No Abstract]   [Full Text] [Related]  

  • 24. Verapamil for the treatment of clozapine-induced persistent sinus tachycardia in a patient with schizophrenia: a case report and literature review.
    Das P; Kuppuswamy PS; Rai A; Bostwick JM
    Psychosomatics; 2014; 55(2):194-5. PubMed ID: 23820380
    [No Abstract]   [Full Text] [Related]  

  • 25. Clozapine-induced myoclonus: two case reports.
    Barak Y; Levine J; Weisz R
    J Clin Psychopharmacol; 1996 Aug; 16(4):339-40. PubMed ID: 8835715
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
    Croissant B; Hermann D; Olbrich R
    Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report of clozapine-induced neutropenia and rechallenge.
    Bavle A; Vidhyavathi M
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e61. PubMed ID: 25716496
    [No Abstract]   [Full Text] [Related]  

  • 28. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
    Illing M; Ancill R
    Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis, hyperglycemia, pleural effusion, eosinophilia, hematuria and proteinuria occurring early in clozapine treatment.
    Thompson J; Chengappa KN; Good CB; Baker RW; Kiewe RP; Bezner J; Schooler NR
    Int Clin Psychopharmacol; 1998 Mar; 13(2):95-8. PubMed ID: 9669191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
    Berecz R; Glaub T; Kellermann M; de la Rubia A; Llerena A; Degrell I
    Pharmacopsychiatry; 2000 Jan; 33(1):42-4. PubMed ID: 10721883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abrupt Improvement in Obsessive-Compulsive Symptoms Upon Discontinuation of Clozapine.
    Dykema LR
    J Clin Psychopharmacol; 2018 Feb; 38(1):88-89. PubMed ID: 29210866
    [No Abstract]   [Full Text] [Related]  

  • 32. Clozapine-induced lupus erythematosus.
    Wolf J; Sartorius A; Alm B; Henn FA
    J Clin Psychopharmacol; 2004 Apr; 24(2):236-8. PubMed ID: 15206677
    [No Abstract]   [Full Text] [Related]  

  • 33. Clozapine therapy and pulmonary embolism.
    Coodin S; Ballegeer T
    Can J Psychiatry; 2000 May; 45(4):395. PubMed ID: 10813078
    [No Abstract]   [Full Text] [Related]  

  • 34. Benign ethnic neutropenia and clozapine monitoring.
    Blackman G
    J Am Acad Child Adolesc Psychiatry; 2008 Aug; 47(8):967-8. PubMed ID: 18645423
    [No Abstract]   [Full Text] [Related]  

  • 35. Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report.
    Pigato G; Toffanin T; Perini GI
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):153-5. PubMed ID: 18801403
    [No Abstract]   [Full Text] [Related]  

  • 36. Fatal fulminant hepatitis following administration of clarithromycin in a patient chronically treated with antipsycotic drugs.
    Maggi P; Solarino B; Cassano P; Tattoli L; Leone A; Maselli E; Angarano G
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):191-4. PubMed ID: 22804484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatotoxicity induced by clozapine: a case report and review of literature.
    Wu Chou AI; Lu ML; Shen WW
    Neuropsychiatr Dis Treat; 2014; 10():1585-7. PubMed ID: 25210451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Worsening of tardive dyskinesia due to clozapine therapy.
    Raguraman J; Vijaysagar J
    J Postgrad Med; 2007; 53(3):218. PubMed ID: 17700005
    [No Abstract]   [Full Text] [Related]  

  • 39. Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice.
    Tovey E; Rampes H; Livingstone C
    J Psychopharmacol; 2005 Mar; 19(2):207-10. PubMed ID: 15728442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic-induced QTc interval prolongation.
    Dewan V; Roth BA
    Can J Psychiatry; 2004 Sep; 49(9):646. PubMed ID: 15503744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.